Prevalence of erectile dysfunction in vascular surgery patients

Juergen Falkensammer, Albert Hakaim, Claudia E. Falkensammer, Gregory A. Broderick, Juliana Crook, Michael G. Heckman, W. Andrew Oldenburg, Beate Hugl

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Erectile dysfunction (ED) is frequently associated with cardiovascular disease. Epidemiological data on the frequency of ED in vascular surgery patients is rarely reported. We evaluated the prevalence of this comorbidity in patients consulting the vascular surgery outpatient clinic. Over a 6-month period, a short version of the International Index of Erectile Function (IIEF) questionnaire consisting of six ED-relevant questions was handed out to 440 vascular surgery outpatients. Clinical data were collected from patients' records. Linear regression models with forward selection were used to investigate associations between erectile function score and possible risk factors. The return rate was 31% (137 patients). Eight patients (6%) were taking phosphodiesterase inhibitors. ED, as defined by an erectile function score of 25 or less and/or use of phosphodiesterase inhibitors, was found in 90% (95% CI: 84% to 95%) of cases. Moderate or severe ED, as defined by an erectile function score of 16 or less and/or use of phosphodiesterase inhibitors, was found in 70% (95% CI: 62% to 78%) of cases. Increased age, abdominal aortic aneurysm, peripheral arterial disease, urologic disease, insulin-dependent diabetes mellitus, and use of beta-blockers were significantly associated with a lower erectile function score. In conclusion, erectile dysfunction is a frequent and often missed comorbidity in vascular surgery patients. While ED may have a profound impact on the patient's quality of life, attention should also be paid to the patient's preoperative sexual function, considering the availability of oral pharmacotherapies and possible consequences concerning liability in postoperative patients in whom pre-existing ED was not identified properly.

Original languageEnglish (US)
Pages (from-to)17-22
Number of pages6
JournalVascular Medicine
Volume12
Issue number1
DOIs
StatePublished - 2007

Fingerprint

Erectile Dysfunction
Blood Vessels
Phosphodiesterase Inhibitors
Comorbidity
Linear Models
Urologic Diseases
Peripheral Arterial Disease
Abdominal Aortic Aneurysm
Ambulatory Care Facilities
Ambulatory Surgical Procedures
Type 1 Diabetes Mellitus
Cardiovascular Diseases
Quality of Life
Drug Therapy

Keywords

  • Cardiovascular disease
  • Erectile dysfunction
  • Prevalence
  • Vascular surgery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Falkensammer, J., Hakaim, A., Falkensammer, C. E., Broderick, G. A., Crook, J., Heckman, M. G., ... Hugl, B. (2007). Prevalence of erectile dysfunction in vascular surgery patients. Vascular Medicine, 12(1), 17-22. https://doi.org/10.1177/1358863X06076043

Prevalence of erectile dysfunction in vascular surgery patients. / Falkensammer, Juergen; Hakaim, Albert; Falkensammer, Claudia E.; Broderick, Gregory A.; Crook, Juliana; Heckman, Michael G.; Oldenburg, W. Andrew; Hugl, Beate.

In: Vascular Medicine, Vol. 12, No. 1, 2007, p. 17-22.

Research output: Contribution to journalArticle

Falkensammer, J, Hakaim, A, Falkensammer, CE, Broderick, GA, Crook, J, Heckman, MG, Oldenburg, WA & Hugl, B 2007, 'Prevalence of erectile dysfunction in vascular surgery patients', Vascular Medicine, vol. 12, no. 1, pp. 17-22. https://doi.org/10.1177/1358863X06076043
Falkensammer, Juergen ; Hakaim, Albert ; Falkensammer, Claudia E. ; Broderick, Gregory A. ; Crook, Juliana ; Heckman, Michael G. ; Oldenburg, W. Andrew ; Hugl, Beate. / Prevalence of erectile dysfunction in vascular surgery patients. In: Vascular Medicine. 2007 ; Vol. 12, No. 1. pp. 17-22.
@article{dd74a2cdfb074b388f99721f397ecd55,
title = "Prevalence of erectile dysfunction in vascular surgery patients",
abstract = "Erectile dysfunction (ED) is frequently associated with cardiovascular disease. Epidemiological data on the frequency of ED in vascular surgery patients is rarely reported. We evaluated the prevalence of this comorbidity in patients consulting the vascular surgery outpatient clinic. Over a 6-month period, a short version of the International Index of Erectile Function (IIEF) questionnaire consisting of six ED-relevant questions was handed out to 440 vascular surgery outpatients. Clinical data were collected from patients' records. Linear regression models with forward selection were used to investigate associations between erectile function score and possible risk factors. The return rate was 31{\%} (137 patients). Eight patients (6{\%}) were taking phosphodiesterase inhibitors. ED, as defined by an erectile function score of 25 or less and/or use of phosphodiesterase inhibitors, was found in 90{\%} (95{\%} CI: 84{\%} to 95{\%}) of cases. Moderate or severe ED, as defined by an erectile function score of 16 or less and/or use of phosphodiesterase inhibitors, was found in 70{\%} (95{\%} CI: 62{\%} to 78{\%}) of cases. Increased age, abdominal aortic aneurysm, peripheral arterial disease, urologic disease, insulin-dependent diabetes mellitus, and use of beta-blockers were significantly associated with a lower erectile function score. In conclusion, erectile dysfunction is a frequent and often missed comorbidity in vascular surgery patients. While ED may have a profound impact on the patient's quality of life, attention should also be paid to the patient's preoperative sexual function, considering the availability of oral pharmacotherapies and possible consequences concerning liability in postoperative patients in whom pre-existing ED was not identified properly.",
keywords = "Cardiovascular disease, Erectile dysfunction, Prevalence, Vascular surgery",
author = "Juergen Falkensammer and Albert Hakaim and Falkensammer, {Claudia E.} and Broderick, {Gregory A.} and Juliana Crook and Heckman, {Michael G.} and Oldenburg, {W. Andrew} and Beate Hugl",
year = "2007",
doi = "10.1177/1358863X06076043",
language = "English (US)",
volume = "12",
pages = "17--22",
journal = "Vascular Medicine (United Kingdom)",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Prevalence of erectile dysfunction in vascular surgery patients

AU - Falkensammer, Juergen

AU - Hakaim, Albert

AU - Falkensammer, Claudia E.

AU - Broderick, Gregory A.

AU - Crook, Juliana

AU - Heckman, Michael G.

AU - Oldenburg, W. Andrew

AU - Hugl, Beate

PY - 2007

Y1 - 2007

N2 - Erectile dysfunction (ED) is frequently associated with cardiovascular disease. Epidemiological data on the frequency of ED in vascular surgery patients is rarely reported. We evaluated the prevalence of this comorbidity in patients consulting the vascular surgery outpatient clinic. Over a 6-month period, a short version of the International Index of Erectile Function (IIEF) questionnaire consisting of six ED-relevant questions was handed out to 440 vascular surgery outpatients. Clinical data were collected from patients' records. Linear regression models with forward selection were used to investigate associations between erectile function score and possible risk factors. The return rate was 31% (137 patients). Eight patients (6%) were taking phosphodiesterase inhibitors. ED, as defined by an erectile function score of 25 or less and/or use of phosphodiesterase inhibitors, was found in 90% (95% CI: 84% to 95%) of cases. Moderate or severe ED, as defined by an erectile function score of 16 or less and/or use of phosphodiesterase inhibitors, was found in 70% (95% CI: 62% to 78%) of cases. Increased age, abdominal aortic aneurysm, peripheral arterial disease, urologic disease, insulin-dependent diabetes mellitus, and use of beta-blockers were significantly associated with a lower erectile function score. In conclusion, erectile dysfunction is a frequent and often missed comorbidity in vascular surgery patients. While ED may have a profound impact on the patient's quality of life, attention should also be paid to the patient's preoperative sexual function, considering the availability of oral pharmacotherapies and possible consequences concerning liability in postoperative patients in whom pre-existing ED was not identified properly.

AB - Erectile dysfunction (ED) is frequently associated with cardiovascular disease. Epidemiological data on the frequency of ED in vascular surgery patients is rarely reported. We evaluated the prevalence of this comorbidity in patients consulting the vascular surgery outpatient clinic. Over a 6-month period, a short version of the International Index of Erectile Function (IIEF) questionnaire consisting of six ED-relevant questions was handed out to 440 vascular surgery outpatients. Clinical data were collected from patients' records. Linear regression models with forward selection were used to investigate associations between erectile function score and possible risk factors. The return rate was 31% (137 patients). Eight patients (6%) were taking phosphodiesterase inhibitors. ED, as defined by an erectile function score of 25 or less and/or use of phosphodiesterase inhibitors, was found in 90% (95% CI: 84% to 95%) of cases. Moderate or severe ED, as defined by an erectile function score of 16 or less and/or use of phosphodiesterase inhibitors, was found in 70% (95% CI: 62% to 78%) of cases. Increased age, abdominal aortic aneurysm, peripheral arterial disease, urologic disease, insulin-dependent diabetes mellitus, and use of beta-blockers were significantly associated with a lower erectile function score. In conclusion, erectile dysfunction is a frequent and often missed comorbidity in vascular surgery patients. While ED may have a profound impact on the patient's quality of life, attention should also be paid to the patient's preoperative sexual function, considering the availability of oral pharmacotherapies and possible consequences concerning liability in postoperative patients in whom pre-existing ED was not identified properly.

KW - Cardiovascular disease

KW - Erectile dysfunction

KW - Prevalence

KW - Vascular surgery

UR - http://www.scopus.com/inward/record.url?scp=34147217609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147217609&partnerID=8YFLogxK

U2 - 10.1177/1358863X06076043

DO - 10.1177/1358863X06076043

M3 - Article

VL - 12

SP - 17

EP - 22

JO - Vascular Medicine (United Kingdom)

JF - Vascular Medicine (United Kingdom)

SN - 1358-863X

IS - 1

ER -